Abstract Mutations of the AE1 (SLC4A1, Anion-Exchanger 1) gene that codes for band 3, the renal and red cell anion exchanger, are responsible for many cases of familial distal renal tubular acidosis (dRTA). In Southeast Asia this disease is usually recessive, caused either by homozygosity of a single AE1 mutation or by compound heterozygosity of two different AE1 mutations. We describe two unrelated boys in Sarawak with dRTA associated with compound heterozygosity of AE1 mutations. Both had Southeast Asian ovalocytosis (SAO), a morphological abnormality of red cells caused by a deletion of band 3 residues 400-408. In addition, one boy had a DNA sequence abnormality of band 3 residue (G701D), which has been reported from elsewhere in Southeast Asia. The other boy had the novel sequence abnormality of band 3 (Q759H) and profound hemolytic anemia.
Introduction
Distal renal tubular acidosis (dRTA) commonly presents in childhood with failure to thrive, hypokalemic acidosis, rickets, and nephrocalcinosis. It is often inherited, either as an autosomal dominant or recessive, and when inherited usually results from mutations of the AE1 (SLC4A1) gene on chromosome 17 that codes for band 3, the bicarbonate/ chloride exchanger which is present in both the red cell membrane and the basolateral membrane of the alpha-intercalated cell in the renal collecting duct [1, 2] . A rarer recessive form of the disease, usually associated with nerve deafness, is caused by mutations affecting the H + -ATPase on the apical membrane of this renal tubular cell [3, 4] .
Inherited dRTA has not so far been described from Sarawak, a state of eastern Malaysia that occupies much of the northern part of the island of Borneo, but we now report two children in Sarawak with this disease. Both patients had Southeast Asian ovalocytosis (SAO), a morphological red cell abnormality that results from a nine-amino acid deletion of band 3 residues 400-408, and is prevalent in Southeast Asia [5] . SAO by itself does not cause either dRTA or anemia [5, 6, 7] . One of our patients was a mixed race Iban/Chinese child with compound heterozygosity of SAO and a mutation of band 3 residue 701, a combination that has been found in dRTA children in other parts of Southeast Asia [6, 7, 8] ; however, in his case the 701 mutation appeared to be derived from his Chinese father, a race in whom this mutation has not previously been described. The second patient, an Iban child, was a compound heterozygote of SAO with a novel mutation of band 3 residue 759 (band 3 UNIMAS ). Both patients had evidence of increased red cell destruction, which in the second child with the SAO/759 mutations amounted to profound hemolytic anemia. eventful vaginal delivery 9 days post-term, but within the first 24 h developed neonatal jaundice requiring exchange transfusion; red cell G6PD was normal. There was no family history of consanguinity or renal disease. The Chinese father has pulmonary tuberculosis and was unavailable for study, and a sister and brother and stepbrother by the patient's mother's earlier marriage were all well.
The child was well until the age of 5 years, when he was admitted to the local hospital with cough, fever, anorexia, weight loss, generalized weakness, thirst and polyuria. He was a pale and wasted child weighing 9.4 kg, who was hypotonic and too weak to stand, with a palpable spleen, but no clinical evidence of bone disease. Blood film showed typical SAO, Hb 9.0 g/dl; RBC 2.510 6 / mm 3 ; Hct 26.9%; WBC 7,800/mm 3 with 2 nucleated RBC/100 WBC; plasma bilirubin 39 mmol/l (n 3-17); SGOT 89 IU/l; SGPT 84 IU/l; glucose 7.2; urea 4.2 mmol/l; creatinine 53 mmol/l; Na 140, K 2.4, HCO 3 12, Cl 117, Ca 2.50, inorganic phosphate 1.70 mmol/l, alkaline phosphatase 192 IU/l (n 31-115). Hemoglobin electrophoresis was normal. Urine pH was >7.0. Abdominal ultrasound showed bilateral nephrocalcinosis, and urine contained a trace of protein and a slight microscopic excess of red and white cells.
Distal RTA was diagnosed and treatment started with Shohl's solution and a potassium chloride supplement. He improved rapidly, and by the fifth day of admission was active and playing. He was discharged home after 11 days, weighing 11.5 kg. Progress over the next 5 years was uneventful, except for a short hospital readmission for gastroenteritis, at age 6, when his splenomegaly was again noted. His weight at 13.4 kg was below the third percentile; Hb 10.6 g/dl, WBC 7,600 mm 3 ; plasma potassium 3.5, bicarbonate 18, calcium 2.36, inorganic phosphate 1.10 mmol/l; creatinine 53 mmol/l.
Patient 2 and his normal twin sister had uneventful births by vaginal delivery; an elder healthy brother was born 6 years earlier (Fig. 2) . The unrelated Iban parents live in a hut in the grounds of a hostel for the blind, the father blind since measles at the age of six, the mother blind from anophthalmia (congenital absence of both eyes). There is no family history of renal disease or anemia.
He was admitted to hospital at 3 weeks of age with failure to thrive and anemia, weight 2. At 2 years of age, weight was 5.4 kg, Hb 4.8 g/dl, retics 24.3%; rachitic rosary was noted. Blood urea was 4.7 mmol/l, creatinine 62 mmol/l, plasma Na 136, K 2.7, Cl 107, HCO 3 9.7, Ca 2.15, and inorganic phosphate 0.58 mmol/l; blood pH was 7.23, alkaline phosphatase 190 IU/l. Urine pH was >7.0. Liver enzymes were normal. Renal tubular acidosis was diagnosed, and treatment was commenced with Shohl's solution. Subsequent plasma bicarbonate values were usually in the normal range. Hemoglobin slowly rose over the next 8 years, except for a temporary drop to 6.8 g/dl at age 4.5 years that was associated with recurrent generalized impetigo, and the patient did not require further blood transfusions (Fig. 3) . Radiological nephrocalcinosis was shown at the age of 9 years.
When the patient was last seen at the age of 10.5 years, hepatosplenomegaly was still present and his sclerae were slightly icteric; plasma bilirubin was 33 mmol/l (conjugated 9), Hb 11.3 g/dl, WBC 12,300, retics 2.3%. Plasma Na was 135, K 4.4, HCO 3 21.9, Ca 2.35, and inorganic phosphate 1.49 mmol/l; alkaline phosphatase was 232 IU/l. Urine pH by glass electrode, after 3 days without alkali treatment, was 7.02, in keeping with dRTA. Despite the evidence of continuing hemolysis, the blood film showed only SAO. Although there was no clinical evidence of bone disease and acidosis was corrected, growth was still markedly retarded (Fig. 3) . Body weight was 16.5 kg, height 110.5 cm (both less than the third percentile); whereas, at the same age, his twin sister weighed 28 kg and was 138.5 cm tall, and his 14 year-old brother weighed 40 kg, both just under the 25th percentile for weight. 
Methods
Genomic DNA was analyzed by single-strand conformational polymorphism (SSCP) and DNA sequencing. Briefly the coding regions of exons 2-20 of the human AE1 gene were analyzed for SSCP after PCR amplification of genomic DNA in the presence of [ 33 P]-dATP, using primers based on sequences at the intron-exon junctions [9] . DNA sequencing was carried out directly on both strands of PCR products using the Thermo Sequenase [ 
Results
Both probands turned out to be compound heterozygotes of several band 3 mutations. Figure 1 and 2 show the family trees of both patients and the various band 3 mutations found in family members. With the exception of the novel mutation Q759H in patient 2, shown in Fig. 4 , all band 3 mutations uncovered in this study have already been described, and therefore are not separately shown.
Patient 1 has the SAO 400-408 deletion accompanied by the Memphis polymorphism K56E on one allele, and the triple mutations M31T, K56E and G701D on the other allele. The SAO deletion arose from deletion of nucleotides 1198-1224 in exon 11 of the AE1 gene, K56E (Lys56Glu) from a point mutation of A to G in nucleotide 166 of exon 4, M31T (Met31Thr) from a point mutation of T to C in nucleotide 92 of exon 3, and G701D (Gly701Asp) from a point mutation G to A in nucleotide 2102 of exon 17, as described previously [6, 7] . The 400-408 deletion and G701D are the mutations causally related to his dRTA, as residues 31 and 56 are not expressed in the renal band 3 isoform. Patient 1 inherited the SAO deletion and K56E from his mother, and must have inherited M31T, K56E and G701D from his father.
Patient 2 is heterozygous for the SAO 400-408 deletion and K56E on one allele, and heterozygous for D38A and the novel mutation Q759H on the other allele. The D38A mutation (Asp38Ala, Darmstadt polymorphism) arose from a point mutation A to C in nucleotide 113 of exon 4 as described [10] . The Q759H mutation (Gln759His) was caused by a point mutation of G to T in nucleotide 2277 of exon 17 (Fig. 4) . The Q759H mutation and the SAO 400-408 deletion are the mutations that are critical for dRTA, as the others are not expressed in the renal isoform. Q759H is likely to affect band 3 anion exchange, for this mutation alters an amino acid residue that lies in a mobile region of the band 3 molecule thought to be involved in anion translocation [11, 12] . Unfortunately fresh blood samples were not available for anion transport experiments.
Discussion
The dRTA described in our two patients was in both cases the result of mutations affecting the AE1 gene, which codes for the band 3 anion exchanger situated in both the red cell membrane and the basolateral membrane of the renal collecting duct alpha-intercalated cell. In the red cell, this 911 amino acid protein binds to the membrane cytoskeleton and contributes to membrane stability. It is also responsible for bicarbonate/chloride exchange between cytoplasm and surrounding plasma [11] . The renal isoform is truncated of its 65 N-terminal amino acids. It is vital for distal nephron acid excretion, as it permits the bicarbonate ion that accumulates in the tubular cell (a result of proton secretion through the apical membrane) to leave the tubular cell through the basolateral membrane. Distal RTA Both probands had distal renal tubular acidosis, as shown by their hypokalemic acidosis, relatively alkaline urine, and nephrocalcinosis. Clinical features of the disease presented in early childhood, as has previously been described in the recessive forms of the disease; whereas, dominantly inherited dRTA tends to be milder and may not be manifest until late childhood or adult years [1] . Patient 2 had a rachitic rosary when dRTA was first diagnosed, but apart from marginal increases in plasma alkaline phosphatase, neither child showed other clinical evidence of the rickets which is common in Southeast Asian children, with dRTA caused by band 3 mutations [7] . Both patients improved on alkali treatment. However, patient 2, who was the more severely growth-retarded, did not show the growth spurt that is usual in dwarfed dRTA patients when alkali treatment is started [13] , although his acidosis and hypokalemia were corrected and his hemolytic anemia improved markedly (Fig. 3) .
Hemolytic anemia
The relationship of band 3 mutations to hemolytic anemia is complex. Many band 3 mutations are associated with hemolytic anemia, particularly those that cause hereditary spherocytosis, but these rarely cause dRTA [11, 14] . Both our dRTA patients had hemolytic anemia, particularly severe in patient 2, with the characteristic red cell morphology of SAO. However, SAO by itself does not cause anemia, so the excess hemolysis of these patients probably arose from the presence of mutations affecting both band 3 alleles. Hemolytic anemia has been reported in Malaysian and Thai children with dRTA and the compound heterozygote SAO/G701D [7, 8] , as confirmed by the anemia of patient 1 in the present report. Other band 3 compound heterozygotes with both dRTA and hemolytic anemia have included SAO/DV850, SAO/A858D, and DV850/A858D. These patients had red cells with altered properties over and above those found in simple SAO heterozygotes [7] . Patient 2's condition is thus similar to other patients with compound heterozygosity of band 3 mutations affecting the membrane part of the band 3 molecule, but his hemolytic anemia was particularly severe, with hemoglobin values down to 4.8 g/dl. Correction of the acidosis with alkali therapy seemed to lessen the severity of anemia (Fig. 3) , as we also noted in unpublished observations on Malay children with dRTA and the SAO/G701D genotype. The reason for this effect of alkali therapy in improving anemia in these cases is not clear. Two possible explanations are that the biochemical features of untreated dRTA (e.g., lowered plasma pH, bicarbonate or potassium) may impair the erythropoietic response to anemia in these patients with hemolyzing red cells, or might further compromise the survival of these abnormal red cells in the circulation, effects which might not be apparent in other dRTA patients whose red cells have normal band 3.
Band 3 mutations

SAO (D400-408)
Southeast Asian ovalocytosis, present in both our patients, is a morphological red cell abnormality that is widespread in Southeast Asia, including southern Thailand, Malaysia, Indonesia, the Philippines and Papua New Guinea (PNG), with a prevalence as high as 35% in Sulawesi and parts of PNG [5] . The mutation causing SAO is a 27 base-pair deletion in the AE1 gene resulting in deletion of the nine band 3 amino acid residues 400-408. In SAO this mutation is invariably associated with the "Memphis" polymorphism, a substitution of glutamic acid for lysine in position 56 (K56E, Lys56Glu), a finding which is common in the general population and by itself seems to have no disease implications. The SAO gene is always heterozygous, and it appears that homozygosity for the gene is lethal in utero, but by itself heterozygosity of the SAO gene does not cause either hemolytic anemia or urinary acidification defect. The fact that the SAO gene always contains two distinct mutations is evidence of a founder effect. The abnormal gene may have evolved locally in Southeast Asia, because SAO band 3 protects against cerebral malaria [15] .
G701D
This mutation, a substitution of glycine by aspartic acid in position 701, has been reported in dRTA families in several Southeast Asian countries: in northeastern Thailand, where dRTA patients have been homozygous for this mutation [16] ; in southern Thailand and peninsular Malaysia, where affected children have been compound heterozygotes of SAO and G701D [6, 7, 8] as is our patient 1; and, very recently, in the Philippines, where it is usually homozygous [17] . The association of G701D and a second band 3 mutation causing dRTA (compound heterozygosity) has also been found in a single family in northeastern Thailand, where the second band 3 change was the novel mutation S773P, rather than the more usual SAO mutation [18] .
Thai researchers have established that the gene frequency of the G701D mutation in the population of Thailand [19] is 0.23-0.73% in the northern, northeastern and central parts of the country, but no G701D mutations were found in 206 individuals in the south of Thailand. Conversely, they found an allele frequency for the SAO mutation of 1.70% in the south of the country, but no instances of this mutation in the three other areas they studied. We are unaware of any other population studies of AE1 mutations in Southeast Asia, apart from longestablished studies of the prevalence of the SAO phenotype [5] .
All patients with the G701D mutation in whom the relevant band 3 exons (exons 3 and 4) have been sequenced have also had the Memphis mutation (K56E) and a mutation of residue 31 (M31T) in which methionine is replaced by threonine [7, 8, 17 ], as we found in our patient 1. These band 3 residues are not expressed in the kidney, so it is unlikely that these mutations play a part in dRTA, but they do provide evidence of a founder effect for the G701D mutation. The allele carrying the combined M31T, K56E and G701D mutations in family 1 was not derived from the mother with SAO, but must originate in the father, who is of southern Chinese ancestry and, unfortunately, not available for study. We have not been able to find any report of band 3 mutations or dRTA in China, but much of the present population of Southeast Asia is believed to have been descended from people who originated in southern China some 3,000-5,000 years ago [20] . From its widespread distribution, it seems likely that this compound mutation is of great antiquity. It may have originated in northern Thailand or southern China and been carried by migration into present day Malaysia and Sarawak, or been transported by reverse migration from Thailand, where it is relatively common, to the paternal ancestors of patient 1 in southern China.
Q759H (band 3 UNIMAS)
This Q759H mutation in patient 2 has not been previously described. We have not found it, or the G701D mutation, in 18 other dRTA patients in Sarawak, including eight of Iban ancestry, or in 76 unrelated individuals, 27 from Southeast Asia. We believe that Q759H is a novel mutation associated with dRTA in the Sarawak population; however, we cannot formally exclude the possibility that it is a functionally neutral polymorphism because we cannot identify the absence of the DNA sequence abnormality in enough normal individuals. Unfortunately, we are unable to collect DNA samples from a representative normal population in the Borneo Rain Forest at this moment.
The hemolytic anemia of this child was profound, with hemoglobin values down to 4.8 g/dl, and the usual features of reticulocytosis, hepatosplenomegaly and a raised plasma bilirubin. His initial leucocytosis was probably a leukemoid reaction to his marked hemolysis, because his white cell count lessened as his anemia improved, and was only marginally increased to 12,300/mm 2 when his Hb reached 11.3 g/dl. The novel Q759H mutation in this Iban child suggests that band 3 mutations in Southeast Asia tend to be partly segregated along racial lines. The Iban (Sea Dyaks) are one of the indigenous races of Borneo, living mostly inland along the rivers of the island, and they are distinct from the Malays and Chinese who have arrived in more recent historical times. The comparative isolation of the Iban may partly explain why this band 3 mutation has not been found elsewhere in Southeast Asia. We have observed a similar segregation of the mutation DV850 in dRTA patients from the relatively isolated population along the northern coast of PNG [7] . In contrast, the G701D mutation appears to be common and widespread as a cause of familial dRTA in Southeast Asia, being found in Thailand, peninsular Malaysia and the Philippines, countries with more mobile populations than Sarawak or PNG.
